 |
|
A Clinicopathological Comparison of Community-Based and Clinic-Based Cohorts of Patients With Dementia
Fadi Massoud, MD, FRCPC;
Gayatri Devi, MD;
Yaakov Stern, PhD;
Arlene Lawton, RN;
James E. Goldman, MD, PhD;
Yan Liu, MD, MSc;
Steven S. Chin, MD, PhD;
Richard Mayeux, MD, MSc
Arch Neurol. 1999;56:1368-1373.
Objectives To compare the sensitivity and specificity of the clinical diagnosis of Alzheimer disease, the distribution of pathological causes, and the demographic and clinical characteristics of 2 different groups of patients with dementia.
Design Retrospective clinicopathological study.
Setting A memory disorder clinic in a university hospital and a multiethnic community.
Patients Sixty-three patients from a memory disorder clinic and 26 patients from a large community-based study who underwent autopsy after clinical evaluation.
Main Outcome Measures Differential distribution of clinical and pathological findings, with clinicopathological correlations.
Results Clinic patients were younger at diagnosis, more educated, and more likely to be white. Of the 63 clinic patients we evaluated, 29 (46%) had a pathological diagnosis of definite AD, 15 (24%) had a diagnosis of mixed AD, and 19 (30%) had a diagnosis of another type of dementia. The pathological diagnoses in the community patients were distributed as follows: 6 (23%) had definite AD, 6 (23%) had mixed AD, 6 (23%) had cerebrovascular disease, and 8 (31%) had another type of dementia. The difference in distribution of pathological diagnoses between these 2 groups was only significant for cerebrovascular diseases. For patients seen at the clinic, the sensitivity of the clinical diagnosis of AD was 98% and the specificity was 84%; for the community group, the sensitivity was 92% and the specificity was 79%.
Conclusions The difference in sensitivity and specificity of clinical diagnosis was not statistically significant between the groups of clinic patients and community patients. Dementia associated with cerebrovascular disease was more prevalent in the community sample. This difference may be attributable to clinical and demographic differences between the 2 groups.
From the Taub Center for Alzheimer's Disease Research (Drs Devi, Stern, Chin, and Mayeux and Ms Lawton), the Gertrude H. Sergievsky Center (Drs Massoud, Devi, Stern, and Mayeux and Ms Lawton), the Departments of Neurology (Drs Devi, Stern, and Mayeux and Ms Lawton), Psychiatry (Drs Stern and Mayeux), and Pathology (Drs Goldman, Liu, and Chin), and the Division of Epidemiology, School of Public Health (Dr Mayeux), Columbia University College of Physicians and Surgeons and Columbia-Presbyterian Medical Center, New York, NY.
RELATED ARTICLE
Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(11):1421-1422.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Antihypertensive Medication Use and Incident Alzheimer Disease: The Cache County Study
Khachaturian et al.
Arch Neurol 2006;63:686-692.
ABSTRACT
| FULL TEXT
Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease
Prohovnik et al.
Neurology 2006;66:49-55.
ABSTRACT
| FULL TEXT
Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease
Tsuang et al.
Neurology 2005;64:509-513.
ABSTRACT
| FULL TEXT
Mixed Dementia: Emerging Concepts and Therapeutic Implications
Langa et al.
JAMA 2004;292:2901-2908.
ABSTRACT
| FULL TEXT
A Comparison of Family History of Psychiatric Disorders Among Patients With Early- and Late-Onset Alzheimer's Disease
Devi et al.
J. Neuropsychiatry Clin. Neurosi. 2004;16:57-62.
ABSTRACT
| FULL TEXT
Stroke and the Risk of Alzheimer Disease
Honig et al.
Arch Neurol 2003;60:1707-1712.
ABSTRACT
| FULL TEXT
Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals
Salmon et al.
Neurology 2002;59:1022-1028.
ABSTRACT
| FULL TEXT
Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
Knopman et al.
Neurology 2001;56:1143-1153.
ABSTRACT
| FULL TEXT
Cerebrospinal Fluid {beta}-Amyloid and Tau Proteins for the Diagnosis of Alzheimer Disease
Knopman
Arch Neurol 2001;58:349-350.
FULL TEXT
Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan
Tang et al.
Neurology 2001;56:49-56.
ABSTRACT
| FULL TEXT
|
